Patents by Inventor Jose ESTEVAM

Jose ESTEVAM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND MATERIALS FOR ASSESSING RESPONSE TO PLASMABLAST- AND PLASMA CELL-DEPLETING THERAPIES
    Publication number: 20230357426
    Abstract: The present disclosure relates to anti-CD38 antibodies and their use as therapeutics and diagnostics. The present disclosure further relates to methods of treating autoimmune diseases, such as systemic lupus erythematosus and rheumatoid arthritis. The present disclosure further relates to diagnostic assay methods for identifying patients having autoimmune diseases for treatment.
    Type: Application
    Filed: February 15, 2023
    Publication date: November 9, 2023
    Inventors: Glennda Smithson, Jose Estevam, Nicholas Jones
  • Methods and materials for assessing response to plasmablast- and plasma cell-depleting therapies
    Patent number: 11613586
    Abstract: The present disclosure relates to anti-CD38 antibodies and their use as therapeutics and diagnostics. The present disclosure further relates to methods of treating autoimmune diseases, such as systemic lupus erythematosus and rheumatoid arthritis. The present disclosure further relates to diagnostic assay methods for identifying patients having autoimmune diseases for treatment.
    Type: Grant
    Filed: July 14, 2017
    Date of Patent: March 28, 2023
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Glennda Smithson, Jose Estevam, Nicholas Jones
  • METHODS AND MATERIALS FOR ASSESSING RESPONSE TO PLASMABLAST- AND PLASMA CELL-DEPLETING THERAPIES
    Publication number: 20190322756
    Abstract: The present disclosure relates to anti-CD38 antibodies and their use as therapeutics and diagnostics. The present disclosure further relates to methods of treating autoimmune diseases, such as systemic lupus erythematosus and rheumatoid arthritis. The present disclosure further relates to diagnostic assay methods for identifying patients having autoimmune diseases for treatment.
    Type: Application
    Filed: July 14, 2017
    Publication date: October 24, 2019
    Inventors: Glennda SMITHSON, Jose ESTEVAM, Nicholas JONES